Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Contextualizing web-based decision support for endocrine therapy for breast cancer risk reduction: Usability and context insights in a cluster randomized trial.

Created on 18 Nov 2026

Authors

Julia D Caci, Alissa Michel, Peter Zeiger, Anna Vaynrub, Cynthia Law, Vicky Ro, Christina Hijya, Garnet L Anderson, Kathryn B Arnold, Sam Dzingle, Sandhya Pruthi, Ana Sandoval-Leon, Rachel Shirley, Maria T Grosse Perdekamp, Sarah V Colonna, Stacy Krisher, Tari A King, Lisa D Yee, Tarah J Ballinger, Christa Braun-Inglis, Debra A Mangino, Kari B Wisinski, Claudia A DeYoung, Masey Ross, Justin Floyd, Andrea Kaster, Lindi H VanderWalde, Thomas J Saphner, Corrine Zarwan, Shelly Lo, Cathy L Graham, Alison K Conlin, Kathleen Y Butler, Doreen M Agnese, Cheryl L Jernigan, Dawn L Hershman, Marian L Neuhouser, Jason A Zell, Banu K Arun, Rita Kukafka, Katherine D Crew

Published in

Cancer prevention research (Philadelphia, Pa.). Nov 18, 2026. Epub Nov 18, 2026.

Abstract

Despite the benefit of endocrine therapy (ET) for breast cancer risk reduction among high-risk women, uptake remains low. In the MiCHOICE trial, we evaluated the effectiveness of a patient decision support tool, RealRisks, compared to standard educational materials in improving informed choice among women with high-risk breast lesions. We found no significant difference in informed choice, but about half initiated ET. To better understand these outcomes, we conducted a qualitative study to explore factors influencing the effectiveness of this tool. We conducted interviews among patients and clinicians assigned to the intervention arm. Interviews were analyzed using the Technology Acceptance Model (TAM). Among 15 enrolled clinicians, 87% were female and 73% were breast surgeons or oncologists. Among 23 enrolled patients, median age was 49.7 years and 70% completed RealRisks. Patients and clinicians found RealRisks' multimodal presentation of risk to be useful, priming patients for the clinic visit and facilitating more productive conversations regarding ET. However, ease of use was limited by technological barriers and navigation challenges. Patients indicated that RealRisks reinforced clinic conversations rather than changing decisions. Despite positive patient and clinician attitudes toward RealRisks, targeted refinements to the decision aid are needed to translate perceived usefulness into measurable improvements in informed choice. The effectiveness of decision aids may depend not only on their content, but on timing and clinical context. Further studies should evaluate these tools among high-risk women identified in screening mammography or primary care, where impact may be greater.

PMID:
43046302
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement